US Patent Issued to Stichting Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis on Feb. 17 for "ABT-751 and ionizing radiation" (Dutch Inventors)

ALEXANDRIA, Va., Feb. 17 -- United States Patent no. 12,551,471, issued on Feb. 17, was assigned to Stichting Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis (Amsterdam).

"ABT-751 and ionizing radiation" was invented by Olaf Van Tellingen (Amsterdam) and Mark Cornelis De Gooijer (Amsterdam).

According to the abstract* released by the U.S. Patent & Trademark Office: "The current invention relates to a combination therapy comprising administering the antimitotic agent ABT-751 to a subject and delivering ionizing radiation to the same subject for the treatment of a brain tumor. Provided is for ABT-751 and ionizing radiation for use in such treatments."

The patent was filed on Jan. 20, 2021, under Application No. 17/792,915...